Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patients

Barbosa, Jakeline Ribeiro; Cortes, Vanessa Faria; Portilho, Moyra Machado; Miguel, Juliana Custódio; Marques, Vanessa Alves; Bezerra, Cristianne Sousa; Souza, Natalia Vasconcelos de; Lima, Danielle Malta; Colares, Jeová Keny Baima; Lewis-Ximenez, Lia Laura; Lampe, Elisabeth; Villar, Livia Melo

Article

Registro en:

BARBOSA, Jakeline; et al. Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patients. J Clin Pathol, v.71, p.879–884, 2018.

0021-9746

https://www.arca.fiocruz.br/handle/icict/31574

10.1136/jclinpath-2018-205024

1472-4146

https://repositorioslatinoamericanos.uchile.cl/handle/2250/8852887

Autor

Barbosa, Jakeline Ribeiro

Cortes, Vanessa Faria

Portilho, Moyra Machado

Miguel, Juliana Custódio

Marques, Vanessa Alves

Bezerra, Cristianne Sousa

Souza, Natalia Vasconcelos de

Lima, Danielle Malta

Colares, Jeová Keny Baima

Lewis-Ximenez, Lia Laura

Lampe, Elisabeth

Villar, Livia Melo

Institución

Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Brasil)

Resumen

Point of care testing (POCT) has been used for hepatitis B and C diagnosis in general population, but little is known about the influence of clinical conditions in the accuracy of these assays. This study aims to evaluate the performance of POCTs for detection of hepatitis B virus surface antigen (HBsAg) and antibodies to Hepatitis C Virus (anti-HCV) in Chronic Kidney Disease (CKD) patients.

2030-01-01